⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2024

Supplemental Figure S17 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy

Tianyi Liu Dan Jin Son B. Le Dongjiang Chen Mathew Sebastian Alberto Riva Ruixuan Liu David D. Tran

View at Publisher

Ask AI

Bookmark

Share

Abstract

Human PU.1 + IKZF1 (hP-IKZF1 or PI) is 3-30-fold more efficient at inducing CD45+ and CD45+MHCII+ cells, respectively, compared to hP-ev alone. (Supporting Main Figure 7)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efee26 https://doi.org/10.1158/2326-6066.27142777

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Figure S21 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024
2Supplemental Figure S23 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024
3Supplemental Figure S16 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024
4Supplemental Figure S9 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024
5Supplemental Figure S14 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024

More related papers

Supplemental Figure S8 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024
Supplemental Figure S18 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024
Supplemental Figure S5 from Machine Learning–Directed Conversion of Glioblastoma Cells to Dendritic Cell–Like Antigen-Presenting Cells as Cancer Immunotherapy2024